If you are working in any of the following scientific/business topic areas, we encourage you to submit a proposal for a podium presentation. We are especially looking for case studies with new data on the following:

  • Antibody Libraries, Selection, Screening and Engineering
  • Novel Therapeutic Targets/Non-Cancer Indications
  • Targeting Subcellular Trafficking Pathways to Generate Antibody Therapeutics
  • Tumor-conditional Immunotherapy
  • BioInformatics and Computational Tools for Antibody Optimization and Engineering
  • Tissue Specific Delivery of Antibodies
  • Engineering and Application of Therapeutic Antibodies for Neurodegenerative Diseases
  • Looking at Targets Differently
  • Systems Immunology for Therapeutic Target Discovery
  • Effector Functions of Therapeutic Antibodies
  • Preclinical Development of Antibody-based Therapeutics
  • Antibody Therapeutic Clinical Case Studies
  • China Interactions Propelling Antibody R&D Around the World: Basic Research and Drug Development to Clinical Studies and Manufacturing
  • Advances in Bispecific Antibody Development
  • Advances in Antibody-Drug Conjugate (ADC) Development
  • Emerging Technologies and Approaches for Antibody Engineering

Submit a Proposal

Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

Presentations should be free of commercial bias as well as any references to commercial products and services. All selected faculty are required to disclose the existence of any significant financial interest. Financial interest may affect the consideration of your presentation/proposal application.

You will be notified by the Event Review Committee if your presentation has been selected.

Call for Speakers

Deadline to submit is Friday, April 26, 2019

December 9-13, 2019
Marriott Marquis San Diego,
San Diego, CA

December 9-13, 2019
Marriott Marquis San Diego
San Diego, CA

Antibody Engineering & Therapeutics

Terms and Conditions  |  Privacy Policy

† You may still receive emails from us regarding any current registrations or orders.